Medi Schwall Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 924.87%
- Profit Growth 239.65%
- Ebitda -193.54%
- Net Worth 321.42%
- Total Assets 354.70%
About Medi Schwall Pharma
Medi Schwall Pharma Private Limited (MSPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 19 August 2019 (Five years and six months 4 days old ). Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Syed Quadri, Mohammed Siddiqui, and Syed Quadri serve as directors at the Company.
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304MH2019PTC329435
- Company No.
329435
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Medi Schwall Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Syed Quadri  | Director | 19-Aug-2019 | Current |
| Mohammed Siddiqui | Director | 19-Aug-2019 | Current |
| Syed Quadri | Director | 10-May-2023 | Current |
Financial Performance of Medi Schwall Pharma.
Medi Schwall Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 924.87% increase. The company also saw a substantial improvement in profitability, with a 239.65% increase in profit. The company's net worth Soared by an impressive increase of 321.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medi Schwall Pharma?
Unlock access to Medi Schwall Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medi Schwall Pharma?
Unlock and access historical data on people associated with Medi Schwall Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medi Schwall Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medi Schwall Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.